HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment vs DSP Nifty Healthcare ETF-Direct Plan
NAV, returns and costs — not a recommendation.
 HDFC Pharma and Healthcare Fund Direct Plan IDCW Reinvestment |  DSP Nifty Healthcare ETF-Direct Plan | |
|---|---|---|
| NAV | ₹22.3 | ₹16.5779 |
| NAV date | 2026-08-18 | 2026-08-19 |
| 1 year | +25.46% | -88.75% |
| 3 year (p.a.) | +32.38% | -53.05% |
| 5 year (p.a.) | +32.38% | -53.05% |
| Expense ratio | 0.92% | 0.17% |
| Fund size | ₹2362.44 Cr | ₹17.23 Cr |
| Risk | — | Very high |
| Category | Sectoral Pharma and Healthcare | Etfs |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.